Biotech pioneer bets a billion on Alzheimer's program - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News

Biotech pioneer bets a billion on Alzheimer's program - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News: "Orrie Friedman was one of the pioneers of biotechnology, but at 92 it's still way too early to start talking retirement. He's now betting that his company, Grand Pharma, can generate some excitement around the notion that silica-based compounds can dissolve amyloid plaques, which are associated with Alzheimer's. He's also betting that a new paper on their work will grab the attention of a deep-pocketed pharma company and that a successful development program will create a billion-dollar windfall. Oh, and he wants to give most of that money away."